Selected research
Industry Research
Cinacalcet Industry Research Report 2026
Market perspective
The global Cinacalcet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cinacalcet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cinacalcet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cinacalcet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cinacalcet include Teva, Sun Pharmaceutical, Shijiazhuang No. 4 Pharmaceutical Co., Ltd., Mylan, Amgen, Steris Healthcare PVT Ltd, Nexus Lifecare Private Limited, Cipla and Cinasun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cinacalcet market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cinacalcet Market by Company
Teva
Sun Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Mylan
Amgen
Steris Healthcare PVT Ltd
Nexus Lifecare Private Limited
Cipla
Cinasun
Camber
Bts Synergy Pvt Ltd
Aurobindo Pharma
Cinacalcet Segment by Type
30 mg Tablets
60 mg Tablets
90 mg Tablets
Cinacalcet Segment by Application
Hospital
Drug store
Cinacalcet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinacalcet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cinacalcet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinacalcet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cinacalcet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cinacalcet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cinacalcet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 30 mg Tablets
- 60 mg Tablets
- 90 mg Tablets
Applications
- Hospital
- Drug store
Companies covered
- Teva
- Sun Pharmaceutical
- Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
- Mylan
- Amgen
- Steris Healthcare PVT Ltd
- Nexus Lifecare Private Limited
- Cipla
- Cinasun
- Camber
- Bts Synergy Pvt Ltd
- Aurobindo Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cinacalcet Market Size (2021-2032)
- 2.2.2 Global Cinacalcet Sales (2021-2032)
- 2.2.3 Global Cinacalcet Market Average Price (2021-2032)
- 2.3 Cinacalcet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 30 mg Tablets
- 2.3.3 60 mg Tablets
- 2.3.4 90 mg Tablets
- 2.4 Cinacalcet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cinacalcet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cinacalcet Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Cinacalcet Revenue of Manufacturers (2021-2026)
- 3.4 Global Cinacalcet Average Price by Manufacturers (2021-2026)
- 3.5 Global Cinacalcet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cinacalcet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cinacalcet, Product Type & Application
- 3.8 Global Manufacturers of Cinacalcet, Established Date
- 3.9 Global Cinacalcet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Cinacalcet Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Cinacalcet Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
- 4.3.1 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Cinacalcet Product Portfolio
- 4.3.5 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Cinacalcet Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Amgen
- 4.5.1 Amgen Company Information
- 4.5.2 Amgen Business Overview
- 4.5.3 Amgen Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Amgen Cinacalcet Product Portfolio
- 4.5.5 Amgen Recent Developments
- 4.6 Steris Healthcare PVT Ltd
- 4.6.1 Steris Healthcare PVT Ltd Company Information
- 4.6.2 Steris Healthcare PVT Ltd Business Overview
- 4.6.3 Steris Healthcare PVT Ltd Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Steris Healthcare PVT Ltd Cinacalcet Product Portfolio
- 4.6.5 Steris Healthcare PVT Ltd Recent Developments
- 4.7 Nexus Lifecare Private Limited
- 4.7.1 Nexus Lifecare Private Limited Company Information
- 4.7.2 Nexus Lifecare Private Limited Business Overview
- 4.7.3 Nexus Lifecare Private Limited Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nexus Lifecare Private Limited Cinacalcet Product Portfolio
- 4.7.5 Nexus Lifecare Private Limited Recent Developments
- 4.8 Cipla
- 4.8.1 Cipla Company Information
- 4.8.2 Cipla Business Overview
- 4.8.3 Cipla Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cipla Cinacalcet Product Portfolio
- 4.8.5 Cipla Recent Developments
- 4.9 Cinasun
- 4.9.1 Cinasun Company Information
- 4.9.2 Cinasun Business Overview
- 4.9.3 Cinasun Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cinasun Cinacalcet Product Portfolio
- 4.9.5 Cinasun Recent Developments
- 4.10 Camber
- 4.10.1 Camber Company Information
- 4.10.2 Camber Business Overview
- 4.10.3 Camber Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Camber Cinacalcet Product Portfolio
- 4.10.5 Camber Recent Developments
- 4.11 Bts Synergy Pvt Ltd
- 4.11.1 Bts Synergy Pvt Ltd Company Information
- 4.11.2 Bts Synergy Pvt Ltd Business Overview
- 4.11.3 Bts Synergy Pvt Ltd Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bts Synergy Pvt Ltd Cinacalcet Product Portfolio
- 4.11.5 Bts Synergy Pvt Ltd Recent Developments
- 4.12 Aurobindo Pharma
- 4.12.1 Aurobindo Pharma Company Information
- 4.12.2 Aurobindo Pharma Business Overview
- 4.12.3 Aurobindo Pharma Cinacalcet Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Aurobindo Pharma Cinacalcet Product Portfolio
- 4.12.5 Aurobindo Pharma Recent Developments
5 Global Cinacalcet Market Scenario by Region
- 5.1 Global Cinacalcet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cinacalcet Sales by Region: 2021-2032
- 5.2.1 Global Cinacalcet Sales by Region: 2021-2026
- 5.2.2 Global Cinacalcet Sales by Region: 2027-2032
- 5.3 Global Cinacalcet Revenue by Region: 2021-2032
- 5.3.1 Global Cinacalcet Revenue by Region: 2021-2026
- 5.3.2 Global Cinacalcet Revenue by Region: 2027-2032
- 5.4 North America Cinacalcet Market Facts & Figures by Country
- 5.4.1 North America Cinacalcet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cinacalcet Sales by Country (2021-2032)
- 5.4.3 North America Cinacalcet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cinacalcet Market Facts & Figures by Country
- 5.5.1 Europe Cinacalcet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cinacalcet Sales by Country (2021-2032)
- 5.5.3 Europe Cinacalcet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cinacalcet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cinacalcet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cinacalcet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cinacalcet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cinacalcet Market Facts & Figures by Country
- 5.7.1 South America Cinacalcet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cinacalcet Sales by Country (2021-2032)
- 5.7.3 South America Cinacalcet Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cinacalcet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cinacalcet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cinacalcet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cinacalcet Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cinacalcet Sales by Type (2021-2032)
- 6.1.1 Global Cinacalcet Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Cinacalcet Sales Market Share by Type (2021-2032)
- 6.2 Global Cinacalcet Revenue by Type (2021-2032)
- 6.2.1 Global Cinacalcet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cinacalcet Revenue Market Share by Type (2021-2032)
- 6.3 Global Cinacalcet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cinacalcet Sales by Application (2021-2032)
- 7.1.1 Global Cinacalcet Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Cinacalcet Sales Market Share by Application (2021-2032)
- 7.2 Global Cinacalcet Revenue by Application (2021-2032)
- 7.2.1 Global Cinacalcet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cinacalcet Revenue Market Share by Application (2021-2032)
- 7.3 Global Cinacalcet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cinacalcet Value Chain Analysis
- 8.1.1 Cinacalcet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cinacalcet Production Mode & Process
- 8.2 Cinacalcet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cinacalcet Distributors
- 8.2.3 Cinacalcet Customers
9 Global Cinacalcet Analyzing Market Dynamics
- 9.1 Cinacalcet Industry Trends
- 9.2 Cinacalcet Industry Drivers
- 9.3 Cinacalcet Industry Opportunities and Challenges
- 9.4 Cinacalcet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst